PUBLISHER: Grand View Research | PRODUCT CODE: 2017888
PUBLISHER: Grand View Research | PRODUCT CODE: 2017888
The global veterinary diagnostics market size was estimated at USD 8.4 billion in 2025 and is projected to reach USD 19.2 billion by 2033, growing at a CAGR of 11.0% from 2026 to 2033. The market is expanding steadily as pet adoption worldwide increases and owners allocate more spending toward routine veterinary examinations and preventive testing.
Routine blood work, screening panels, and early disease detection have become common components of companion animal care. In parallel, the continued occurrence of infectious and zoonotic diseases in livestock and pets is creating sustained demand for reliable diagnostic tools to support disease control, herd productivity, and food supply safety.
Moreover, the need for faster, more streamlined diagnostic processes is driving growth in the veterinary diagnostics market. In many clinics, evaluating a pet's health can take time, particularly where access to specialized clinical pathologists or parasitologists is limited. For instance, according to an article published by Zoetis in February 2026, veterinary practices in the United States collectively perform around 90 million fecal tests each year, reflecting the scale of routine diagnostic workload. Such high testing volumes are increasing interest in advanced in-clinic diagnostic systems that can shorten turnaround time, improve operational efficiency, and help veterinarians make timely treatment decisions, thereby contributing to greater adoption of modern diagnostic solutions.
Furthermore, broader adoption of structured clinical guidelines is increasing the use of detailed diagnostic workups in veterinary practice. For instance, according to an article published by AVMA, in February 2026, the American Veterinary Medical Association reported on a consensus statement from the American College of Veterinary Internal Medicine addressing chronic inflammatory enteropathy (CIE) in dogs. The document outlines a two-tier diagnostic pathway that recommends a stepwise evaluation, including detailed case history, use of standardized scoring indices such as CIBDAI and CCECAI, routine laboratory testing, imaging studies, and dietary trials before moving to invasive procedures. As clinics incorporate these recommendations into daily practice to improve case management and long-term monitoring, utilization of blood panels, fecal analysis, imaging, and related diagnostic services is likely to increase, contributing to the continued expansion of the veterinary diagnostics market.
In addition, ongoing advances in veterinary molecular testing the expanding the veterinary diagnostics market by improving the accuracy and timeliness of disease detection in both companion and production animals. Laboratory methods that analyze genetic material and protein markers are enabling veterinarians to identify infections and disorders earlier than with conventional techniques, supporting more targeted treatment decisions. For instance, in February 2026, BioVenic advanced this trend by expanding its veterinary molecular diagnostic development services, providing research teams with end-to-end technical support for new testing platforms. Efforts such as these are helping bring more precise and commercially viable molecular diagnostic tools to market, contributing to the continued growth of the sector.
Global Veterinary Diagnostics Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the veterinary diagnostics market report based on product, testing category, animal, end use, and region: